Given that both CD133− and CD133+ cells from metastatic CRC tumors have the potential to establish xenografts [6], and, in order to capture the heterogeneity of the original human tumor as much as possible, the decision was made to use unsorted CRC tumor cells for xenotransplantation in all subsequent experiments. The gene discussed is PROM1; the disease is colorectal carcinoma.